
Tempus AI reports 23% revenue growth and $193M from new data deals over 5 years
Tempus AI reported a 23% year-over-year revenue increase to $411.5 million in Q3 2026, driven by rising test prices and multiyear biopharma licensing agreements expected to generate $193 million over five years. The company also anticipates an $80 mi...

